1. Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI). (May 2023) Authors: Watts, J.; Smith, B.; Bradley, T.; Skikne, B.; Mendler, J.; Klimek, V.; Thomassen, A.; Stopcyzinski, T.; Chen, S.-C.; Run, F.; Anderson, I.; Moncrief, A.; Madhu, S.; Sochacki, A.; Kishtagari, A.; Strickland, S.; Byrne, M.; Ayers, G.; Mohan, S.; Moyo, T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗